| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 |
| filingDate |
2012-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad9b558a502ee640b119e5aad7f5bf4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af2b239690cd15ccf84072a5693657e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3eded024e4a8faaf147c93b78ef7d8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e232b788c9e4a6f9f5cd6154890b2871
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7d4b48327265a7b1db5739b28f04870 |
| publicationDate |
2017-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2012257849-B2 |
| titleOfInvention |
Lixisenatide and metformin for treatment of diabetes type 2 |
| abstract |
The present invention refers to a pharmaceutical combination for glycemic control in diabetes type 2 patients. It concerns the combination of lixisenatide (AVEOOIO), a GLP-1 agonist, and metformin. |
| priorityDate |
2011-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |